TY - JOUR AU - Melero, I. AU - Gaudernack, G. AU - Gerritsen, W. AU - Huber, C. AU - Parmiani, G. AU - Scholl, S. PY - 2014 DA - 2014// TI - Therapeutic vaccines for cancer: an overview of clinical trials JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.111 DO - 10.1038/nrclinonc.2014.111 ID - Melero2014 ER - TY - JOUR AU - Van Der Burg, S. H. AU - Arens, R. AU - Ossendorp, F. AU - Van Hall, T. AU - Melief, C. J. M. PY - 2016 DA - 2016// TI - Vaccines for established cancer: overcoming the challenges posed by immune evasion JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.16 DO - 10.1038/nrc.2016.16 ID - Van Der Burg2016 ER - TY - JOUR AU - Bol, K. F. AU - Schreibelt, G. AU - Gerritsen, W. R. AU - IJM, D. V. AU - Figdor, C. G. PY - 2016 DA - 2016// TI - Dendritic cell-based immunotherapy: state of the art and beyond JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-1399 DO - 10.1158/1078-0432.CCR-15-1399 ID - Bol2016 ER - TY - JOUR AU - Antonarakis, E. S. AU - Kibel, A. S. AU - Yu, E. Y. AU - Karsh, L. I. AU - Elfiky, A. AU - Shore, N. D. PY - 2017 DA - 2017// TI - Sequencing of sipuleucel-T and androgen deprivation therapy in men with hormone-sensitive biochemically recurrent prostate cancer: a phase II randomized trial JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-1780 DO - 10.1158/1078-0432.CCR-16-1780 ID - Antonarakis2017 ER - TY - JOUR AU - Kantoff, P. W. AU - Higano, C. S. AU - Shore, N. D. AU - Berger, E. R. AU - Small, E. J. AU - Penson, D. F. PY - 2010 DA - 2010// TI - Sipuleucel-T immunotherapy for castration-resistant prostate Cancer JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa1001294 DO - 10.1056/NEJMoa1001294 ID - Kantoff2010 ER - TY - JOUR AU - Türeci, Ö. AU - Vormehr, M. AU - Diken, M. AU - Kreiter, S. AU - Huber, C. AU - Sahin, U. PY - 2016 DA - 2016// TI - Targeting the heterogeneity of cancer with individualized neoepitope vaccines JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-1509 DO - 10.1158/1078-0432.CCR-15-1509 ID - Türeci2016 ER - TY - JOUR AU - Carreno, B. M. AU - Magrini, V. AU - Becker-Hapak, M. AU - Kaabinejadian, S. AU - Hundal, J. AU - Petti, A. A. PY - 2015 DA - 2015// TI - A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells JO - Science VL - 348 UR - https://doi.org/10.1126/science.aaa3828 DO - 10.1126/science.aaa3828 ID - Carreno2015 ER - TY - JOUR AU - Su, Z. AU - Dannull, J. AU - Heiser, A. AU - Yancey, D. AU - Pruitt, S. AU - Madden, J. PY - 2003 DA - 2003// TI - Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells JO - Cancer Res VL - 63 ID - Su2003 ER - TY - JOUR AU - Nestle, F. O. AU - Alijagic, S. AU - Gilliet, M. AU - Sun, Y. AU - Grabbe, S. AU - Dummer, R. PY - 1998 DA - 1998// TI - Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells JO - Nat Med VL - 4 UR - https://doi.org/10.1038/nm0398-328 DO - 10.1038/nm0398-328 ID - Nestle1998 ER - TY - JOUR AU - Kandalaft, L. E. AU - Chiang, C. L. AU - Tanyi, J. AU - Motz, G. AU - Balint, K. AU - Mick, R. PY - 2013 DA - 2013// TI - A phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer JO - J Transl Med VL - 11 UR - https://doi.org/10.1186/1479-5876-11-149 DO - 10.1186/1479-5876-11-149 ID - Kandalaft2013 ER - TY - JOUR AU - Alfaro, C. AU - Perez-Gracia, J. L. AU - Suarez, N. AU - Rodriguez, J. AU - Fernandez de Sanmamed, M. AU - Sangro, B. PY - 2011 DA - 2011// TI - Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, Pegylated IFN, and cyclophosphamide for metastatic Cancer patients JO - J Immunol VL - 187 UR - https://doi.org/10.4049/jimmunol.1102209 DO - 10.4049/jimmunol.1102209 ID - Alfaro2011 ER - TY - STD TI - Rodríguez-Ruiz ME, Perez-Gracia JL, Rodríguez I, Alfaro C, Oñate C, Pérez G, et al. Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients. Ann Oncol. 2018;29(5):1312–19. ID - ref12 ER - TY - JOUR AU - Tanyi, J. L. AU - Bobisse, S. AU - Ophir, E. AU - Tuyaerts, S. AU - Roberti, A. AU - Genolet, R. PY - 2018 DA - 2018// TI - Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancer JO - Sci Transl Med VL - 10 UR - https://doi.org/10.1126/scitranslmed.aao5931 DO - 10.1126/scitranslmed.aao5931 ID - Tanyi2018 ER - TY - JOUR AU - Inogés, S. AU - Tejada, S. AU - Cerio, A. L. -. D. AU - Pérez-Larraya, J. G. AU - Espinós, J. AU - Idoate, M. A. PY - 2017 DA - 2017// TI - A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients JO - J Transl Med VL - 15 UR - https://doi.org/10.1186/s12967-017-1202-z DO - 10.1186/s12967-017-1202-z ID - Inogés2017 ER - TY - CHAP AU - Brenner, H. AU - Kloor, M. AU - Pox, C. P. PY - 2014 DA - 2014// TI - Colorectal cancer BT - The Lancet ID - Brenner2014 ER - TY - JOUR AU - de Jong, M. C. AU - Pulitano, C. AU - Ribero, D. AU - Strub, J. AU - Mentha, G. AU - Schulick, R. D. PY - 2009 DA - 2009// TI - Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients JO - Ann Surg VL - 250 ID - de Jong2009 ER - TY - JOUR AU - Goldberg, R. M. AU - Fleming, T. R. AU - Tangen, C. M. AU - Moertel, C. G. AU - Macdonald, J. S. AU - Haller, D. G. PY - 1998 DA - 1998// TI - Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection JO - Ann Intern Med VL - 129 UR - https://doi.org/10.7326/0003-4819-129-1-199807010-00007 DO - 10.7326/0003-4819-129-1-199807010-00007 ID - Goldberg1998 ER - TY - JOUR AU - Spolverato, G. AU - Pawlik, T. M. PY - 2014 DA - 2014// TI - Liver-directed therapies: surgical approaches, alone and in combination with other interventions JO - Am Soc Clin Oncol Educ B VL - 34 UR - https://doi.org/10.14694/EdBook_AM.2014.34.101 DO - 10.14694/EdBook_AM.2014.34.101 ID - Spolverato2014 ER - TY - JOUR AU - Kusano, M. AU - Honda, M. AU - Okabayashi, K. AU - Akimaru, K. AU - Kino, S. AU - Tsuji, Y. PY - 2017 DA - 2017// TI - Randomized controlled phase III study comparing hepatic arterial infusion with systemic chemotherapy after curative resection for liver metastasis of colorectal carcinoma: JFMC 29–0003 JO - J Cancer Res Ther VL - 13 UR - https://doi.org/10.4103/0973-1482.184524 DO - 10.4103/0973-1482.184524 ID - Kusano2017 ER - TY - JOUR AU - Vermorken, J. B. AU - Claessen, A. M. AU - van Tinteren, H. AU - Gall, H. E. AU - Ezinga, R. AU - Meijer, S. PY - 1999 DA - 1999// TI - Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial JO - Lancet VL - 353 UR - https://doi.org/10.1016/S0140-6736(98)07186-4 DO - 10.1016/S0140-6736(98)07186-4 ID - Vermorken1999 ER - TY - JOUR AU - Nagashima, I. AU - Takada, T. AU - Okinaga, K. AU - Nagawa, H. PY - 2005 DA - 2005// TI - A scoring system for the assessment of the risk of mortality after partial hepatectomy in patients with chronic liver dysfunction JO - J Hepato-Biliary-Pancreat Surg VL - 12 UR - https://doi.org/10.1007/s00534-004-0953-0 DO - 10.1007/s00534-004-0953-0 ID - Nagashima2005 ER - TY - JOUR AU - Fong, Y. AU - Fortner, J. AU - Sun, R. L. AU - Brennan, M. F. AU - Blumgart, L. H. PY - 1999 DA - 1999// TI - Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases JO - Ann Surg VL - 230 UR - https://doi.org/10.1097/00000658-199909000-00004 DO - 10.1097/00000658-199909000-00004 ID - Fong1999 ER - TY - JOUR AU - Kaplan, E. L. AU - Meier, P. PY - 1958 DA - 1958// TI - Nonparametric estimation from incomplete observations JO - J Am Stat Assoc VL - 53 UR - https://doi.org/10.1080/01621459.1958.10501452 DO - 10.1080/01621459.1958.10501452 ID - Kaplan1958 ER - TY - JOUR AU - Schemper, M. AU - Smith, T. L. PY - 1996 DA - 1996// TI - A note on quantifying follow-up in studies of failure time JO - Control Clin Trials VL - 17 UR - https://doi.org/10.1016/0197-2456(96)00075-X DO - 10.1016/0197-2456(96)00075-X ID - Schemper1996 ER - TY - JOUR AU - Schadendorf, D. AU - Ugurel, S. AU - Schuler-Thurner, B. AU - Nestles, F. O. AU - Enk, A. AU - Bröcker, E. B. PY - 2006 DA - 2006// TI - Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG JO - Ann Oncol VL - 17 UR - https://doi.org/10.1093/annonc/mdj138 DO - 10.1093/annonc/mdj138 ID - Schadendorf2006 ER - TY - JOUR AU - Bol, K. F. AU - van den Bosch, T. AU - Schreibelt, G. AU - Mensink, H. W. AU - Keunen, J. E. E. AU - Kiliç, E. PY - 2016 DA - 2016// TI - Adjuvant dendritic cell vaccination in high-risk Uveal melanoma JO - Ophthalmology VL - 123 UR - https://doi.org/10.1016/j.ophtha.2016.06.027 DO - 10.1016/j.ophtha.2016.06.027 ID - Bol2016 ER - TY - JOUR AU - Mlecnik, B. AU - Bindea, G. AU - Angell, H. K. AU - Maby, P. AU - Angelova, M. AU - Tougeron, D. PY - 2016 DA - 2016// TI - Integrative analyses of colorectal Cancer show Immunoscore is a stronger predictor of patient survival than microsatellite instability JO - Immunity VL - 44 UR - https://doi.org/10.1016/j.immuni.2016.02.025 DO - 10.1016/j.immuni.2016.02.025 ID - Mlecnik2016 ER - TY - JOUR AU - Le, D. T. AU - Uram, J. N. AU - Wang, H. AU - Bartlett, B. R. AU - Kemberling, H. AU - Eyring, A. D. PY - 2015 DA - 2015// TI - PD-1 blockade in tumors with mismatch-repair deficiency JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1500596 DO - 10.1056/NEJMoa1500596 ID - Le2015 ER - TY - JOUR AU - Kim, J. E. AU - Hong, Y. S. AU - Ryu, M. H. AU - Lee, J. L. AU - Chang, H. M. AU - Lim, S. B. PY - 2011 DA - 2011// TI - Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancer JO - Cancer Sci VL - 102 UR - https://doi.org/10.1111/j.1349-7006.2011.02009.x DO - 10.1111/j.1349-7006.2011.02009.x ID - Kim2011 ER - TY - JOUR AU - Versteven, M. AU - Van den Bergh, J. M. J. AU - Marcq, E. AU - Smits, E. L. J. AU - Van Tendeloo, V. F. I. AU - Hobo, W. PY - 2018 DA - 2018// TI - Dendritic cells and programmed death-1 blockade: a joint venture to combat cancer JO - Front Immunol VL - 9 UR - https://doi.org/10.3389/fimmu.2018.00394 DO - 10.3389/fimmu.2018.00394 ID - Versteven2018 ER - TY - STD TI - Forde PM, Chaft JE, Smith KN, Anagnostou V, Cottrell TR, Hellmann MD, et al. Neoadjuvant PD-1 blockade in Resectable lung Cancer. N Engl J Med. 2018;24;378(21):1976–86. ID - ref31 ER - TY - JOUR AU - Melero, I. AU - Berraondo, P. AU - Rodríguez-Ruiz, M. E. AU - Pérez-Gracia, J. L. PY - 2016 DA - 2016// TI - Making the most of cancer surgery with neoadjuvant immunotherapy JO - Cancer Discov. VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-16-1109 DO - 10.1158/2159-8290.CD-16-1109 ID - Melero2016 ER - TY - JOUR AU - Liu, J. AU - Blake, S. J. AU - Yong, M. C. R. AU - Harjunpää, H. AU - Ngiow, S. F. AU - Takeda, K. PY - 2016 DA - 2016// TI - Improved efficacy of neoadjuvant compared to adjuvant immunotherapy to eradicate metastatic disease JO - Cancer Discov VL - 6 UR - https://doi.org/10.1158/2159-8290.CD-16-0577 DO - 10.1158/2159-8290.CD-16-0577 ID - Liu2016 ER -